[HTML][HTML] A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi …
AV De Keersmaecker, E Van Doninck… - Frontiers in …, 2024 - frontiersin.org
Introduction: Despite advances in immunomodulatory treatments of multiple sclerosis (MS),
patients with non-active progressive multiple sclerosis (PMS) continue to face a significant …
patients with non-active progressive multiple sclerosis (PMS) continue to face a significant …
[HTML][HTML] A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi …
AV De Keersmaecker, E Van Doninck… - Frontiers in …, 2024 - frontiersin.org
Introduction: Despite advances in immunomodulatory treatments of multiple sclerosis (MS),
patients with non-active progressive multiple sclerosis (PMS) continue to face a significant …
patients with non-active progressive multiple sclerosis (PMS) continue to face a significant …